SFX by Ex Libris Inc.

Title:	Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture
Source:	Science [0036-8075] Chou, J yr:1990

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Pataraia, E. "Abstracts of the 5th Joint Meeting of the German, Austrian, and Swiss Sections of the International League Against Epilepsy Basle, May 16-19, 2007.(Author abstract)." Epilepsia 48.s3 (2007): 1-1.
description	2.	Andreansky, S. "Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors." Cancer research 57.8 (1997): 1502-9.
description	3.	Lasner, Todd M. "Toxicity and neuronal infection of a HSV-1 ICP34.5 mutant in nude mice." Journal of neurovirology 4.1 (1998): 100-105.
description	4.	Liu, Z-Q L. "ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties." Gene therapy 10.4 (2003): 292-303.
description	5.	Hnatowich, A L. "The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method." Journal of immunological methods 65.1-2 (1984): 147-57.
description	6.	Yarze, Joseph C. C. "LIVER.(Author abstract)(Concert review)(Survey)(Clinical report)." The American journal of gastroenterology 102.s2 (2007): 215-.
description	7.	Varghese, S. "Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates." Human gene therapy 12.8 (2001): 999-1010.
description	8.	Ryall, L. "Laboratories should use serum IgM tests to confirm measles." BMJ. British medical journal (Clinical research ed.) 312.7036 (1996): 975-.
description	9.	Poonian, M S. "Covalent attachment of nucleic acids to agarose for affinity chromatography." Biochemistry 10.3 (1971): 424-.
description	10.	Haber, Daniel A. "Circulating tumor cells: approaches to isolation and characterization." The Journal of cell biology 192.3 (2011): 373-382.
description	11.	York, I A A. "A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes." Cell 77.4 (1994): 525-535.
description	12.	Cattaneo, R. "Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded." Nature reviews. Microbiology 6.7 (2008): 529-40.
description	13.	Malick, A. "Experimental therapy of human glioma by means of a genetically engineered virus mutant." Science 252.5007 (1991): 854-856.
description	14.	Advani, S J J. "Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications." Clinical microbiology and infection 8.9 (2002): 551-63.
description	15.	Todo, T. "Oncolytic herpes simplex virus type 1 and host immune responses." Current cancer drug targets 7.2 (2007): 149-55.
description	16.	Wung, Hwang-Ling L. "[Teaching patient-centered holistic care]." hu li za zhi 54.3 (2007): 27-32.
description	17.	Vellas, B J J. "Fear of falling and restriction of mobility in elderly fallers." Age and Ageing 26.3 (1997): 189-93.
description	18.	Marien, P. "The lateralized linguistic cerebellum: a review and a new hypothesis." Brain and Language 79.3 (2002): 580-600.
description	19.	m, Sverker P. "Remembering, knowing and the Tulving-Wiseman law." The European Journal of Cognitive Psychology 9.2 (1997): 167-185.
description	20.	Stott, Shannon L. "Isolation of circulating tumor cells using a microvortex-generating herringbone-chip." Proceedings of the National Academy of Sciences of the United States of America 107.43 (2010): 18392-18397.